Portugal – Pharmaceutical products – C/ BASE NO CPA SPMS 2025/1303 - TRASTUZUMAB DERUXTECANO 100 MG PÓ CONC SOL INJ FR IV
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Acquisition of Trastuzumab deruxtecan 100 mg Powder conc sol inj Fr IV